respiratory disease
The partners have formed a consortium called Universal CRISPR-based Detection Platform for Versatile and Rapid Diagnostics (UNCOVER).
Boulud also provided additional information on the company's Q4 performance, noting that it placed 900 SpotFire point-of-care PCR instruments during the quarter.
AmplifiDx Nabs $954K in RADx Funding for POC Test Instrument Development
The funding will support the development of the AmplifiDx Dx 100 Platform for use with a nucleic acid amplification test for respiratory infections.
At the ADLM annual meeting, firms said they see game-changing opportunities for platforms that provide the right combination of clinical utility and convenience.
The Berlin, Germany-based firm said it plans to expand its test menu to take on many more infectious diseases with its portable molecular instrument.